Surveillance of SARS-CoV-2 variants in Henan, China from 2023 to 2024
ObjectiveIn January 2023, China implemented the “Class B Management” policy, marking a new phase in COVID-19 control. As new SARS-CoV-2 variants continue to emerge, some have shown significant immune evasion, posing challenges to epidemic control efforts. To manage the pandemic effectively, Henan Pr...
Saved in:
Main Authors: | Yun Song, Bicong Wu, Hongxia Ma, Yafei Li, Su Yan, Jingjing Pan, Haifeng Wang, Ying Ye, Xueyong Huang, Wanshen Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1511114/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01) -
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01) -
Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
by: Shuaibing Dong, et al.
Published: (2024-12-01) -
Non-Stoichiometric Ba<sub>x</sub>Mn<sub>0.7</sub>Cu<sub>0.3</sub>O<sub>3</sub> Perovskites as Catalysts for CO Oxidation: Optimizing the Ba Content
by: Álvaro Díaz-Verde, et al.
Published: (2025-01-01) -
Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)